Professor | Yi Yao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yi Yao
Contact Information	yaoyi2018@whu.edu.cn
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Yi Yao

Contact Information

yaoyi2018@whu.edu.cn

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1998-2003: Bachelor of Clinical Medicine, Wuhan University 2003-2008: PhD in Internal Medicine, Wuhan University Received funding from the National Natural Science Foundation of China and other provincial and educational grants
Work Experience	2008.07-2008.11: Resident Physician, Cancer Center, Renmin Hospital, Wuhan University 2008.12-2012.11: Attending Physician, Cancer Center, Renmin Hospital, Wuhan University 2012.12-present: Associate Chief Physician, Cancer Center, Renmin Hospital, Wuhan University 2014.07-2015.09: Visiting Scholar, Heidelberg University Hospital, Germany 2016.08-2016.09: Visiting Scholar, MD Anderson Cancer Center, USA 2022.09-present: Director, Department of Oncology, Renmin Hospital, Wuhan University
Awards	Hubei Province Natural Science Excellent Academic Paper, Second Prize Chinese Medical Association Medical Education Branch, Teaching Research Achievement, Second Prize Huangshi City Science and Technology Progress, Second Prize Wuhan University Renmin Hospital 'Medical Elite', 'People's Anti-Epidemic Model'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1998-2003: Bachelor of Clinical Medicine, Wuhan University
2003-2008: PhD in Internal Medicine, Wuhan University
Received funding from the National Natural Science Foundation of China and other provincial and educational grants

Work Experience

2008.07-2008.11: Resident Physician, Cancer Center, Renmin Hospital, Wuhan University
2008.12-2012.11: Attending Physician, Cancer Center, Renmin Hospital, Wuhan University
2012.12-present: Associate Chief Physician, Cancer Center, Renmin Hospital, Wuhan University
2014.07-2015.09: Visiting Scholar, Heidelberg University Hospital, Germany
2016.08-2016.09: Visiting Scholar, MD Anderson Cancer Center, USA
2022.09-present: Director, Department of Oncology, Renmin Hospital, Wuhan University

Awards

Hubei Province Natural Science Excellent Academic Paper, Second Prize
Chinese Medical Association Medical Education Branch, Teaching Research Achievement, Second Prize
Huangshi City Science and Technology Progress, Second Prize
Wuhan University Renmin Hospital 'Medical Elite', 'People's Anti-Epidemic Model'

Areas of Focus	Tumor microenvironment and precision therapy DNA damage repair and antitumor therapy
Publications	FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis, Y Yao et al., 2023 Turbulence of Glutamine Metabolism in Pan-cancer Prognosis and Immune Microenvironment, Y Yao et al., 2022 Irradiation enhances the malignancy-promoting behaviors of cancer-associated fibroblasts, Y Yao et al., 2022 Identification and validation for biological characteristic and prognosis of tumor microenvironment subtypes in patients with lung adenocarcinoma, Y Yao et al., 2022 Comprehensive analysis identifies and validates the tumor microenvironment subtypes to predict anti-tumor therapies efficacy in Hepatocellular carcinoma, Y Yao et al., 2022 A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma, Y Yao et al., 2022 Tumor-educated platelets facilitate thrombus formation through migration, Y Yao et al., 2022 Predict radiation pneumonitis using a genome-scale flux analysis on RNA-seq derived from peripheral blood, Y Yao et al., 2021 Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study, Y Yao et al., 2021 Risk factors for distant metastasis of patients with primary triple-negative breast cancer, Y Yao et al., 2019 Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study, Y Yao et al., 2019 Radiotherapy after surgery has significant survival benefits for patients with triple negative breast cancer, Y Yao et al., 2019 Detecting EGFR Mutations and ALK/ROS1 Rearrangements in Non-Small Cell Lung Cancer Using Malignant Pleural Effusion Samples, Y Yao et al., 2019 Naringenin ameliorates radiation-induced lung injury by lowering IL-1β level, Y Yao et al., 2018 Mesenchymal stem cells: a double-edged sword in radiation-induced lung injury, Y Yao et al., 2018

Areas of Focus

Tumor microenvironment and precision therapy
DNA damage repair and antitumor therapy

Publications

FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis, Y Yao et al., 2023
Turbulence of Glutamine Metabolism in Pan-cancer Prognosis and Immune Microenvironment, Y Yao et al., 2022
Irradiation enhances the malignancy-promoting behaviors of cancer-associated fibroblasts, Y Yao et al., 2022
Identification and validation for biological characteristic and prognosis of tumor microenvironment subtypes in patients with lung adenocarcinoma, Y Yao et al., 2022
Comprehensive analysis identifies and validates the tumor microenvironment subtypes to predict anti-tumor therapies efficacy in Hepatocellular carcinoma, Y Yao et al., 2022
A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma, Y Yao et al., 2022
Tumor-educated platelets facilitate thrombus formation through migration, Y Yao et al., 2022
Predict radiation pneumonitis using a genome-scale flux analysis on RNA-seq derived from peripheral blood, Y Yao et al., 2021
Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study, Y Yao et al., 2021
Risk factors for distant metastasis of patients with primary triple-negative breast cancer, Y Yao et al., 2019
Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study, Y Yao et al., 2019
Radiotherapy after surgery has significant survival benefits for patients with triple negative breast cancer, Y Yao et al., 2019
Detecting EGFR Mutations and ALK/ROS1 Rearrangements in Non-Small Cell Lung Cancer Using Malignant Pleural Effusion Samples, Y Yao et al., 2019
Naringenin ameliorates radiation-induced lung injury by lowering IL-1β level, Y Yao et al., 2018
Mesenchymal stem cells: a double-edged sword in radiation-induced lung injury, Y Yao et al., 2018

Tumor Microenvironment Precision Therapy Dna Damage Repair Mechanisms Cancer Therapy Oncology Cellular Response Molecular Targeting Therapeutic Strategies Clinical Outcomes

Jianyang Hu - Southern University of Science and Technology

Lin Congyao - Wuhan University

Hai-Xia Ding - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us